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Profiling spermatogenic failure in adult testes
bearing Sox9-deficient Sertoli cells identifies genes
involved in feminization, inflammation and stress
Aurélie Lardenois1, Frédéric Chalmel1, Francisco Barrionuevo2,4, Philippe Demougin3, Gerd Scherer2,
Michael Primig1*
Abstract
Background: Sox9 (Sry box containing gene 9) is a DNA-binding transcription factor involved in chondrocyte
development and sex determination. The protein’s absence in testicular Sertoli nurse cells has been shown to
disrupt testicular function in adults but little is known at the genome-wide level about molecular events
concomitant with testicular break-down.
Methods: To determine the genome-wide effect on mRNA concentrations triggered by the absence of Sox9 in
Sertoli cells we analysed adult testicular tissue from wild-type versus mutant mice with high-density
oligonucleotide microarrays and integrated the output of this experiment with regulatory motif predictions and
protein-protein network data.
Results: We report the genome-wide mRNA signature of adult testes lacking Sox9 in Sertoli cells before and after
the onset of late spermatogenic failure as compared to fertile controls. The GeneChip data integrated with
evolutionarily conserved Sox9 DNA binding motifs and regulatory network data identified genes involved in
feminization, stress response and inflammation.
Conclusions: Our results extend previous observations that genes required for female gonadogenesis are up-
regulated in the absence of Sox9 in fetal Sertoli cells to the adult stage. Importantly, we identify gene networks
involved in immunological processes and stress response which is reminiscent of a phenomenon occurring in a
sub-group of infertile men. This suggests mice lacking Sox9 in their Sertoli cells to be a potentially useful model for
adult human testicular failure.
Background
Sex differentiation of mammalian males is controlled by
the Y-chromosomal locus Sry (Sex-determining region
of Y-chromosome) which, in cooperation with Steroido-
genic factor 1 (Sf1), directly activates the expression of
Sox9 [1]; for review, see [2]. This protein is an important
transcription factor involved in various developmental
processes and pathologies [3]. Sox9 is expressed in sup-
porting cell precursors destined to become Sertoli cells
which are required for normal testis morphology and
germ cell development [4-6]; reviewed in [7,8]. Sox9 is
actively imported into the nucleus during male gonad
development [9,10] and specifically interacts with the
A/TACAA
T/A motif via its high mobility group (HMG)
DNA binding and DNA bending domain [2,11]. The
protein is thought to stimulate its own expression via a
C-terminal transactivation domain together with Sf1
after the sex determination stage when Sry expression is
repressed; reviewed in [2,12].
Human SOX9 was found to be mutated in patients suf-
fering from campomelic dysplasia, a condition linked
with abnormal skeletal development and, critically, per-
turbed male gonadogenesis or complete sex reversal
[13,14]. This is in keeping with an important role for the
rodent Sox9 protein in murine male gonad development
initially suggested on the basis of its expression pattern
[5,6]. Experiments addressing Sox9’s reproductive
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function were complicated by the fact that homozygous
constitutive mutant mouse embryos die before the onset
of sex differentiation [15]. Therefore, earlier work
demonstrating the protein’s critical role in the process of
pre-natal testis development was based on Sertoli cell-
specific partial or complete ablation of Sox9 in the mouse
embryo prior to the initial stage of testis development
[16,17]. Recently it was reported that Sertoli-cell specific
deletion of Sox9 at embryonic day 14 (E14.0) - two and a
half days after the sex determination stage - had no effect
on the formation of seminiferous tubules and early adult
testicular function; however, at late stages testicular
architecture and spermatogenesis were disrupted [18].
These results suggest critical roles for Sox9 during pre-
natal sex determination and in adult maintenance of
spermatogenesis. However, nothing is known about the
global impact of Sox9’s absence in adult Sertoli cells at
the molecular level [19].
Here we investigate the testicular genome-wide mRNA
concentration profile in adult mice bearing an AMH-
Cre transgene and two Sox9 alleles with Cre recognition
sites (AMH-Cre Sox9flox/flox). Testicular samples from
mice whose Sertoli-cells lack Sox9 from E14.0 onwards
were isolated before the onset of infertility at the age of
90 days post partum (dpp) and at 165 dpp, when the
phenotype was clearly detectable. These samples were
compared to controls homozygous for a functional Sox9
allele (Sox9flox/flox) taken at the same age. The output of
the expression profiling study was integrated with a gen-
ome-wide search for evolutionarily conserved Sox9 bind-
ing sites to help identify potential direct targets and with
regulatory network data to explore systemic effects in the
mutant. Our results reveal a complex mRNA signature in
part due to changing testicular cell proportions and to
the up-regulation of genes involved in female gonad
development but also possibly to the de-regulation of
mouse genes involved in stress response and inflamma-
tion not previously reported in the context of spermato-
genic failure.
Methods
Mouse strains
Mice bearing Sox9flox/flox [20] and AMH-Cre transgenes
[21] were crossed to obtain AMH-Cre Sox9flox/flox mice
which were genotyped as published [18].
Testicular sample preparation
Total testis samples were prepared from C57BL/6 Sox9-
flox/flox and AMH-Cre Sox9flox/flox mutant animals at 3
(90 dpp) and 5.5 (165 dpp) month after birth. Testes of
at least three animals for each time points were decap-
sulated and combined into duplicate pools using stan-
dard laboratory practice.
Target synthesis, GeneChip hybridization and raw data
production
Total RNA preparation, cRNA target synthesis and raw
data production using Mouse Genome 430 2.0 Gene-
Chips (Affymetrix) were essentially done as previously
published [22].
Expression data analysis
The microarray data were pre-processed and analyzed
using the AMEN (Annotation, Mapping, Expression and
Network analysis) suite of tools [23]. The data quality
was verified by plotting the surface intensity distribu-
tion, 3’-5’ RNA degradation and log2 signal distribution
across samples. Data were normalized using the Robust
Multi-Array Average (RMA) method as previously pub-
lished and the global signal intensities from Sox9flox/flox
and mutant AMH-Cre Sox9flox/flox samples were visua-
lized using a Distance Matrix in combination with a
dendrogram as published [22,24].
Statistical filtration and classification
Probe sets yielding a signal higher than the detection
threshold (median of the normalized dataset, cutoff 5.3)
and a fold-change ≥2.0 between Sox9flox/flox and AMH-
Cre Sox9flox/flox at 90 and 165 dpp were selected.
A LIMMA statistical test (F-value adjusted with the
False Discovery Rate method: p ≤ 0.01) was employed to
identify significantly differentially expressed probe sets
which were subsequently classified into two groups
using the k-means algorithm (k = 2).
Gene Ontology (GO) and transcription factor binding site
(TFBS) enrichment
Enrichment of GO terms and predicted TFBSs were
estimated with the Fisher exact probability using a
Gaussian Hypergeometric test as previously published
[22]. A GO term or a TFBS matrix was considered to be
significantly enriched in a group of genes when the
FDR-corrected p-value was ≤0.01 and the number of
genes bearing this annotation or a TFBS was ≥5.
Regulatory network analysis
The network representation was drawn using AMEN
[23]. The protein-gene regulation data were downloaded
from the TRANSFAC Professional Database release
2010.1 [25] and from Transcription Factor Encyclopedia
(TFe, accessed May 1st, 2010).
Prediction of TFBSs conserved across species
Transcriptional Start Sites (TSS) extracted from all_mrna.
txt and refseqAli.txt UCSC mapping files were localized by
associating annotated mouse protein-coding genes (mm9
genome) with their corresponding transcripts as defined in
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the gene2accession file provided by the NCBI [26]. TFBSs
matrices from the TRANSFAC Professional Database
release 2010.1 were predicted using the MATCH software
[27] with the minSUM_good profile to minimize false
negative and false positive predictions. Motif predictions
were limited to a region of 1 kb upstream of the Tran-
scriptional Start Site (TSS). Motifs displaying a core simi-
larity score (CSS) and a matrix similarity score (MSS) of
≥0.8 were selected. To further reduce the number of false
positives potential motifs had to be conserved [28]. For
each prediction a cross-species conservation score was
computed by averaging the base-by-base phastCons scores
calculated between 30 vertebrates as provided by the
UCSC genome browser [29]. Predicted motifs with a con-
servation score ≥0.8 were selected. Mouse genes whose
promoters contained at least one predicted motif were
used to calculate its enrichment as compared to the pro-
moters of all annotated genes.
MIAME Compliance
Raw data CEL files corresponding to 8 total testicular sam-
ples collected in duplicate at the age of 90 and 165 dpp
from C57BL/6 Sox9flox/flox and AMH-Cre Sox9flox/flox
mice, respectively, are available via the EBI’s ArrayExpress
under the accession number E-TABM-528 [30]. Normal-
ized data are available for viewing at GermOnline [31].
Results
Experimental design and quality control
It was found earlier that Sertoli-cell specific deletion of
Sox9 from E14 onwards had no effect on the fertility of
young adults but caused late spermatogenic failure due
to progressive degeneration of the seminiferous tubules
[18]. To gain insight into which Sox9-dependent pro-
cesses may contribute to this phenotype we compared
the testicular mRNA profiles of phenotypically normal
Sox9flox/flox mice and mutant AMH-Cre Sox9flox/flox
mice. As a control, samples from both backgrounds
were first taken at 90 dpp prior to the onset of the phe-
notype where testes from Sox9flox/flox and AMH-Cre
Sox9flox/flox mice are morphologically and histologically
indistinguishable. A second set of samples was prepared
at 165 dpp which is approximately two weeks after the
point where pathological changes first become histologi-
cally apparent, but well before testicular architecture
breaks down completely in the AMH-Cre Sox9flox/flox
background [18]. Affymetrix Mouse Genome 430 2.0
high-density oligonucleotide GeneChips are extremely
robust tools that yield highly reproducible data [32,33]
and complex mammalian samples are amenable to reli-
able analysis when examined in duplicate [22,24,34]. We
therefore used two independent pooled samples of 90
dpp and 165 dpp testes from Sox9flox/flox and AMH-Cre
Sox9flox/flox mice to prepare total- and cRNA of
uniformly high quality (Additional file 1 Figure S1A and
B). GeneChip hybridization patterns were normal in all
cases (Additional file 1 Figure S1C) and the signals dis-
played the expected RNA degradation and intensity dis-
tribution profiles (Additional file 1 Figure S1D and E).
Testes from Sox9flox/flox and AMH-Cre Sox9flox/flox mice
show distinct mRNA concentration profiles
We first identified 14,106 and 14,438 genes, respectively,
for which signals above the threshold level of detection
(5.3 log2 units corresponding to the median intensity)
were obtained at 90 dpp and 165 dpp (Additional File 2
Table S1). We next selected genes significantly differen-
tially expressed (2-fold change, LIMMA test with FDR
adjusted p-value < 0.01) and used the k-means cluster-
ing algorithm (n = 2) to group them into 16 genes
showing stronger signals and 7 genes showing weaker
signals in the mutant samples at 90 dpp (Figure 1A).
The extremely low number of gene for which variations
were found is in keeping with the lack of any detectable
phenotype at the 90 dpp control time point as compared
to the Sox9flox/flox control. We then repeated the proce-
dure with the 165 dpp samples and identified 1119
genes for which we measured increased signals and 113
genes associated with decreased signals (Figure 2A).
This result is consistent with the morphological changes
observed in testicular tissue after the onset of dysgenesis
at the age of 5 months [18].
Among the loci for which signals are stronger in the
mutant, only two were found exclusively at 90 dpp, 14
were observed in both samples and 1105 were detected
only at 165 dpp. Similarly, three, four and 109 genes
were found to be weaker only at 90 dpp, in both sam-
ples or only at 165 dpp, respectively (Figure 1B and
Additional File 2 Table S1). These results show, as
expected, that a substantial effect on RNA concentra-
tions is detectable only at 165 dpp at the onset of testi-
cular failure.
Increasing and decreasing mRNA concentrations in
AMH-Cre Sox9flox/flox samples are associated with
different testicular cell types and biological processes
We integrated the expression signals obtained with total
testis samples from Sox9flox/flox and AMH-Cre Sox9flox/
flox mice with our data from enriched wild-type Sertoli
cells, spermatogonia, spermatocytes, spermatids and
total testis samples [22] as well as ovary samples
obtained from the GEO public array data repository
(Methods) [35]. We note that the experimental design
allows for determining overall mRNA concentration
changes between replicate samples which may or may
not be due to transcriptional effects. We refer to statisti-
cally significant changes in expression values between
wild-type and mutant testes alternatively as stronger
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(increasing) and weaker (decreasing) signals which
implies that more or less mRNA, respectively, is present
in the given sample.
Figure 2A shows a heatmap summarizing expression
signals for two genes showing stronger signals only at
90 dpp while no increase was found at 165 dpp (Class 1;
Fam181b, Igf1r), 14 genes showing stronger signals at
both time points (Class 2; Aqp5, C3, Ccdc80, Ildr2,
Hoxd10, Lrg1, Serpina3n, Spon1, Sult1e1, Thrsp, Timp1,
Tnfrsf12a, Tspan8, Wwtr1) and 1105 loci which pass
our selection criteria (>2-fold) for a significant signal
increase only at 165 dpp (Class 3; see Additional File 2
A
B
90 dpp 
Up
LIMMA empirical Bayes test 
??0.01 (FDR adjusted)
fold-change wt vs ko
Cutof f  = 2
detection threshold 
Cutof f  = 5.3
Down Up Down
k-means clustering
n = 2
165 dpp
wt versus ko 
90 dpp
4 / 4
14 / 17
165 dpp
0 / 1
0 / 0
109 / 122
3 / 3
1105 / 1353
2 / 3
Down
Up
16/20 7/8 113/126 1119/1371 
33/39 1276/1633 
14438/23652 14106/23041 
wt versus ko 
90 dpp
165 dpp
90 dpp 165 dpp
Figure 1 Gene filtration strategy and output. (A) A schematic drawing outlines the method used to identify and cluster genes showing
statistically significant signal changes across the 90 and 165 dpp time points. The numbers of genes and probe sets are given. (B) A Venn
diagram summarizes the distribution of genes into up and down categories at the time points given.
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Table S1 which contains find and filtering functions to
call up the complete expression data set for individual
genes or groups of loci; see also GermOnline for expres-
sion data freely available for all genes represented on the
Mouse Genome 430 2.0 GeneChip; [36]). For genes in
Class 3 we observe the strongest signals in purified
somatic wild-type Sertoli cells and spermatogonia as
well as ovary (Figure 2A).
Figure 2B depicts the signals for three genes showing
weaker signals only at 90 dpp (Class 4; Kctd14, Schip1,
LOC100044139), four cases where signals were decreased
in both samples (Class 5; Clic6, Diras2, Sox6, Sox9) and
109 loci whose transcript concentrations decrease in the
mutant at 165 dpp (Class 6; Additional File 2 Table S1).
As opposed to the genes shown in panel A we typically
find the loci to display the strongest signals in purified
pachytene spermatocytes and round spermatids; these
results are confirmed by strong signals in testes and
mostly weak ones in ovary (Figure 2B).
We next explored the biological processes associated
with groups of genes showing signal changes among the
sample set by determining if these groups were statisti-
cally significantly enriched for genes bearing specific
Gene Ontology (GO) terms (Methods) (Figure 2C).
Figure 2 Gene clustering and GO term analysis. (A) A false-color heatmap shows cases of increasing (up) mRNA signal intensities across the
replicates (R1, R2) for different total testis samples (top) at the time points given (bottom). They are compared to four different purified testicular
cell types and two external controls (Testis, Ovary). Genes are grouped into three different clusters according to their signal patterns at different
time points (C1-C3). A color scale for log2 transformed data is shown. (B) A similar display is given for genes that display weaker signals in the
mutant samples (down), they were also grouped into clusters (C4-C5). (C) For genes showing stronger signals in the mutant (up) significantly
enriched GO terms and their identification numbers are given (left) together with the number of genes associated with the term (middle) and
the number of genes observed versus expected. A color scale for enriched and depleted terms is show at the bottom.
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While no GO terms were found to be enriched in the
group showing decreased signals, we identified several
relevant processes among the genes for which stronger
signals are observed in the mutant. First, as anticipated,
we found Reproduction (GO:0000003, 62 observed/35
expected by chance, p-value: 3.6 × 10-5), Male sex differ-
entiation (0046661, 12/4, 4.5 × 10-4), and Female sex dif-
ferentiation (0046660, 11/4, 3.8 × 10-3). A large group of
genes was annotated as being involved in Organ devel-
opment (0048513, 169/90, 1.3 × 10-15); consistently, we
find enrichment of terms relevant for bone formation
and the reproductive tract such as Skeletal system devel-
opment (0001501, 37/16, 4.8 × 10-6) and development of
the Urogenital system (0001655, 25/9, 2.3 × 10-5), Pros-
tate gland (0030850, 8/2, 1.5 × 10-3), and Gonad
(0008406, 16/6, 3.7 × 10-4).
At the cellular level we found two terms particularly
pertinent for Sertoli cell- germ cell interactions as sper-
matogenesis progresses: Cell migration (0016477, 37/14,
3.9 × 10-7), and Cell adhesion (0007155, 56/29, 8 × 10-6)
while Phagocytosis (0006909, 11/3, 5 × 10-5) and Apopto-
sis (0006915, 42/26, 3.9 × 10-3) reveal extensive absorp-
tion of cellular material and programmed cell death
typical for Sertoli cells and meiotic germ cells, respec-
tively. As far as biochemical processes important for
reproduction are concerned we identified metabolism of
Prostaglandin (0006693, 7/1, 7.6 × 10-6), and Retinoid
(0001523, 9/2, 1.7 × 10-5).
Interestingly, the group of genes showing increased
signals includes some involved in Signaling (0023033,
102/68, 1.6 × 10-4) and notably Cell surface receptor
linked signaling (0007166, 90/64, 2.9 × 10-3) such as the
MAPKKK cascade (0000165, 16/7, 7.5 × 10-3). These
signal transduction pathways play roles in similarly
enriched processes such as Response to stress (0006950,
154/72, 1.6 × 10-19) and Inflammatory-, (0006954, 38/
13, 6.2 × 10-2) as well as Immune response (0006955,
53/23, 1.1 × 10-7).
These results indicate that reproducible mRNA con-
centration changes occur in AMH-Cre Sox9flox/flox sam-
ples at the onset of testicular breakdown, and that the
group of genes for which we find a signal increase con-
tains more genes involved in male reproductive func-
tions, female sex differentiation, stress response and
inflammatory processes than would be expected to occur
by chance. Lists of genes bearing specific GO annotations
as described are available via Additional File 2 Table S1.
Conserved regulatory motifs are enriched within the
promoters of genes showing signal changes in Sox9flox/flox
versus AMH-Cre Sox9flox/flox testes
To gain further insight into the regulatory processes
that contribute to the RNA signature triggered by the
absence of Sox9 in Sertoli cells, we first identified 202
genes for which mRNA was detectable only in mutant
testes but not the normal controls. We found that the
promoters of these genes - for which we find strong sig-
nals in purified Sertoli cells, spermatogonia and ovary
but not in testis - were statistically significantly enriched
for conserved target sites of Sox9 (Figure 3A-C, Meth-
ods). Moreover, we identified the motifs of regulators
known or thought to be involved in Wnt signaling
(Tcf7l2, Zbtb33/Kaiso), embryonic and post-natal devel-
opment (Maf, Nfia, Pou5f1, Runx2, Tead1, Tef), steroid
hormone signaling (Esr1, Nr2f2), stress response (Nfe2l2,
Ppara) and immune function (Bhlhe40, Cebpa, Cebpb,
Elf1, Irf8, Jun, Stat6) (Figure 3E).
We next selected 23 genes for which mRNA was
detected in Sertoli cells and that showed weaker signals in
AMH-Cre Sox9flox/flox samples to determine if they were
potential direct Sox9 targets. The majority of them showed
the strongest signals in purified meiotic and post-meiotic
germ-cells and among those for which the highest signals
were observed in purified Sertoli cells only five (Mpb,
Tcf7l2, Acaca, Ank2 and Apbb1ip) were below the thresh-
old level of detection in the mutant and had at least one
Sox9 binding site in their upstream promoter regions
(Figure 3D). The only enriched motif identified in the
group showing decreased signals in the mutant was the
target site bound by the Androgen Receptor (Ar) which is
involved in testosterone signaling (Figure 3E).
Testicular failure in AMH-Cre Sox9flox/flox mice is
concomitant with extensive inflammatory and stress-
response network activation
To better understand the level of interconnectivity
between transcription factors and target genes that
responded to the Sox9 deletion we integrated the output
of our analysis with published transcriptional regulatory
data from TRANSFAC and TFe (Methods). We identi-
fied one large network including 14 transcription factors
showing stronger signals in the AMH-Cre Sox9flox/flox
testes and five showing weaker ones (including Sox9
itself for which, as expected, no transcript was detected)
(Figure 4A). Furthermore, we found a small complex
(Irf8 and B2m/Cybb/H2-D1 targets) and two binary
interactions (Zbtb33/S100a4 and Hoxd9/Hoxd10)
(Figure 4B). The interactions typically reveal concordant
patterns for transcription factors and their target genes
in the group of genes showing increased signals in the
mutant. Factors such as Cebpb, Epas1, Irf8, and Jun are
involved in controlling immunological processes often
via regulating cytokine gene expression. The network
data also suggest a certain level of coordination between
immune-, and stress response, development (Cebpa,
Fosl2, Hoxd9, Hoxd10, Maf, Nfe2l2, Nfia, Ppara) and
gene expression controlled by steroid hormone recep-
tors (Ar, Esr1, Nr2f2 and Rxra).
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Figure 3 Combined expression and motif prediction analysis. (A) The method used to identify conserved transcription factor binding sites
(TFBSs) is shown. (B) The identification numbers and the logos of three different Sox9 binding site matrices from TRANSFAC are given. (C) A
heatmap is shown for genes for which mRNAs are detected only in mutant testicular samples (up) in comparison to purified testicular cells and
external controls as in Figure 3. (D) A heatmap for genes showing weaker signals in the mutant (down) and above-background signals in
purified Sertoli cells. The proximal promoters of the genes shown in panels C and D contain at least one predicted Sox9 binding site. A log2
scale is given. (E) Transcription factor symbols and their corresponding binding matrix identifiers (left), the total number of promoter sequences
that contain them (middle), and the numbers of promoters observed versus expected by chance for genes falling into increase and decrease
groups shown in panel A (right) are given. The total numbers in each category is given at the top of the columns. A color scale showing
depletion and enrichment is shown at the bottom. Regulators for which we detect stronger or weaker signals in the mutant are given in red
and blue, respectively.
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Adh1
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Cybb
Acox1
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Figure 4 Regulatory network analysis. (A) The network is color coded with nodes given in red and blue for transcription factors (TF) showing
stronger (up) or weaker (down) signals in the mutant, respectively. Target genes showing stronger or weaker signals in the mutant are given in
dark blue (up) and green (down), respectively. The thickness of the edge represents the number of published protein/DNA interactions (see
Methods). Sox9 is given in blue. (B) Three examples of small regulatory networks are given. A legend for the color code is shown.
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In addition to Sox9, we identified four transcription
factors which displayed weaker signals in AMH-Cre
Sox9flox/flox testes in spite of the fact that their target
genes show a signal increase: Sox6 (development of the
central nervous system, chondrogenesis and mainte-
nance of cardiac and skeletal muscle cells), Pou5fl
(embryonic stem cell pluripotency), Pou2f2 (B-cell
maturation) and Runx2 (chondrocyte-, and osteoblast
differentiation).
Discussion
Targeted deletion of the Sox9 transcription factor in tes-
ticular Sertoli cells at E14.0, after the initial phase of sex
determination, does not prevent spermatogenesis from
being established but causes its progressive degeneration
from the age of five months onwards. The phenotype
includes morphological changes such as reduced testis
size, loss of germ cells in approximately 30% of the
tubules and an increased Leydig cell population [18].
We sought to better understand the molecular events
underlying this effect by establishing whole-genome
RNA concentration profiles of samples from mice bear-
ing the Sox9flox/flox allele as compared to AMH-Cre
Sox9flox/flox animals. To this end, we isolated material
from both strains before (90 dpp) and after (165 dpp)
the onset of testicular degeneration. Because of practical
issues including small sample size and low frequency of
transgenic off-spring, we analysed total testicular tissues
rather than purified cell populations. In the analysis
described here histological observations were combined
with different types of expression-, motif prediction and
gene regulation data to discern biological processes and
to establish a genome-wide signature of a complex pro-
gressive male infertility phenotype. The raw data are
available via the EBI’s ArrayExpress repository (Meth-
ods) and normalized signals were integrated into Addi-
tional file 2 Table S1 and the GermOnline database.
Sox9 is typically (but not exclusively) involved in the
transcriptional activation of its targets genes [19,37].
Therefore we first focused on the group of genes show-
ing diminished mRNA concentrations in AMH-Cre
Sox9flox/flox testis. Among 126 probe-sets displaying a
signal decrease in the AMH-Cre Sox9flox/flox mutant
samples we found 62 to show the strongest signals in
purified meiotic and post-meiotic germ cells indicating
an indirect effect since Sox9 was deleted only in Sertoli
cells. Although the genes corresponding to 25 of them
contained at least one match to a known Sox9 motif in
their proximal promoter region almost none of them
were reliably detected in purified Sertoli cells effectively
ruling them out as direct candidates (with the caveat
that the purification procedure may have affected their
expression). Moreover, in many cases the signals are
only weaker but not abolished. We conclude that for
these genes we find decreased signals most likely
because of diminishing germ cell populations in the
tubules of mutant testis [18].
We reasoned that direct Sox9 Sertoli target genes
should display decreased signals in 90 dpp and 165 dpp
AMH-Cre Sox9flox/flox mutant samples, at least one Sox9
binding motif should be present in their proximal pro-
moter regions and their mRNA should be detectable in
purified wild-type Sertoli cells. The loci we found using
these three selection criteria include Acaca (acetyl-
Coenzyme A carboxylase alpha) which is involved in
fatty acid metabolism; its deletion causes an embryonic
lethal phenotype [38], Mpb (Myelin basic protein) which
encodes a component of the myelin sheath in the cen-
tral nervous system as well as other splice variants asso-
ciated with diverse cellular functions [39], and Ank2
(Ankyrin 2) which is known to be involved in brain and
muscle development [40,41]. Furthermore, we identified
Sox6 which is predominantly expressed in the male
germline but for which mRNA is also detectable in Ser-
toli cells (GermOnline; [22,42]). It was demonstrated
that Sox6 expression is lost in Sox9-deficient limb buds
[43], that the human SOX6 promoter is bound and acti-
vated by Sox9 in chondrogenic cells [44] and that Sox6
helps Sox9 activate a target gene in cartilage [45]. It is
possible that the weaker signal for Sox6 is due to dimin-
ished germ cell numbers at 165 dpp. However, we
observe a two-fold signal reduction already at 90 dpp
when the germ cell content of the seminiferous tubules
is unaffected. It is therefore conceivable that Sox6 plays
an unexpected role in Sertoli cells and that its expres-
sion in this cell type (but not in germ cells) requires
Sox9. Another potentially interesting gene we identified
is Tcf7l2 (transcription factor 7-like 2) which encodes a
protein involved in Wnt signaling [46,47]. It is known
that Sox9 inhibits Wnt signaling in chondrocytes [48]
and that abnormal activation of the Wnt pathway in
mouse Sertoli cells leads to degeneration of tubules and
infertility [49,50], a phenotype reminiscent of the one
reported for AMH-Cre Sox9flox/flox mice [18]. We specu-
late that perturbed Tcf7l2-dependent Wnt signaling
might contribute to late-onset infertility in the absence
of Sox9 in Sertoli cells.
Genes that show higher mRNA concentrations in the
mutant testis or that are detectable only in pathological
tissue reflect increasing cell populations (Leydig cells)
and, predominantly, cellular stress. Examples include the
Leydig cell markers Cyp17, Cyp11a1, Cyp21a1, and Star
[51-53] or Nr2f2 [54] as well as genes that are involved in
cell adhesion (Cml5), structural components such as col-
lagens (Col4a5, Col11a1), keratin (Krt18), metallopro-
teases (Adam8, Adam10, Adamts1, Adamts5) and an
inhibitor of this type of enzyme (Timp1). We also identi-
fied Wnt4 which is involved in female sex determination
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[55-57] (for review see [58]); it was observed previously
that the absence of Sox9 in Sertoli cells triggers de-
repression of genes involved in this process during pre-
and early post-natal stages [16,17]. It is tempting to spec-
ulate that the phenomenon, due to dedifferentiation of
mature Sertoli cells, persists until late adulthood. This is
in keeping with the recent observation that a deletion of
Foxl2 (the antagonist of Sox9 in female gonads) in ovar-
ian follicle cells causes granulosa and theca cells to
acquire Sertoli-, and Leydig cell-like features such as tes-
tosterone production [59] (for review, see [60]).
A potentially interesting result of our study is the
strong immunological component of the RNA signature.
This phenomenon is clearly reflected by the gene net-
works of Jun and Cebpb in particular: most of their tar-
get genes which show increased or even specific signals
in AMH-Cre Sox9flox/flox testes (such as C3ar1, Cd44,
Cd14, Cebpa, Cxcl13, H2-Aa, Icam1, Ildr2, Ly6d, Maob,
Nupr1, and Prdx1) are involved in immunological or
inflammatory processes (see Mouse Genome Database
for references). Interestingly, we also observed loci that
play roles in down-regulating the immune response
which likely reflects a stress response mechanism acti-
vated in increasingly damaged testicular tissue: for
example, we found two serine protease inhibitors Ser-
pinb6b (Serine (or cysteine) peptidase inhibitor, clade B,
member 6B) and Serpina3n, [61], which are known to
act on Granzymes A and B proteases secreted by cyto-
toxic T-lymphocytes [62,63]. Cultured human Sertoli
cells - which are perhaps in a similar state of stress as
Sox9-negative Sertoli cells in degenerating testicular tis-
sue - secrete Serpina3n which was found to bind and
inhibit Granzyme B, revealing a direct mechanism of
Sertoli cell-dependent immunoprotection [64]. We note
that Serpins are also produced by Leydig cells [65] and
their strong mRNA signals may therefore at least in part
be due to the proportional increase of the Leydig cell
population in AMH-Cre Sox9flox/flox samples at 165 dpp
[18]. In this context it is interesting that Serpina5/Pci
plays an important role in male reproduction since
homozygous Serpina5-/- mice cannot maintain the Ser-
toli cell-dependent blood-testis barrier and become
infertile [66]. We found that Serpina5 showed an
mRNA signal increase at 165 dpp (GermOnline, Addi-
tional File 1) which may in part reflect a compensatory
mechanism stemming the disruption of seminiferous
tubules. Moreover, we observed strongly elevated
mRNA concentrations for Spp1 (Secreted phosphopro-
tein 1) a protein thought to play a protective role by
inhibiting apoptosis and by modulating the immune
response [67].
Finally, it is remarkable that some mouse genes that
display increased mRNA concentrations in mutant male
gonads have human orthologs that appear to be up-
regulated in the testes of different types of infertile
patients showing various degrees of spermatogenic fail-
ure [68]. This group of loci includes Adamts5 (a disinte-
grin-like metallopeptidase with thrombospondin type 1
motif, 5; involved in osteoarthritis, [69]), Clec2b (C-type
lectin domain family 1 involved in platelet activation
and aggregation, [70]), Ctsc (Cathepsin C required for
the activation of Granzymes A and B, [71]), Ldlr (Low
density lipoprotein receptor involved in cholesterol
homeostasis, induced by inflammation, [72]), and
Samd9l (Sterile alpha motif domain containing 9-like
involved in cytokine signaling [73]). We note that these
genes are mostly involved in immunological phenomena.
Conclusions
This study aimed at establishing a genome-wide mRNA
signature associated with Sertoli cell-specific deletion of
the Sox9 transcription factor to better understand the
molecular events that are concomitant with - but not cau-
sative of - testicular failure. Our results suggest that Sox9
is required in Sertoli cells to prevent sex reversal until late
adulthood and that AMH-Cre Sox9flox/flox mice are a
potentially useful model system to study testicular dysgen-
esis syndromes [74] and inflammatory processes that
might ultimately contribute to the formation of malignant
tumors [68]. The data pave the way for more detailed his-
tological examinations of both the Sox9 mutant mouse
model and patients presenting with progressive testicular
failure to confirm at the protein level what our microarray
study has revealed at the mRNA level.
Additional material
Additional file 1: Supplemental Figure S1: RNA and data quality
controls. (A) Total RNAs are shown from phenotypically normal (Sox9flox/
flox) and mutant (AMH-Cre Sox9flox/flox) replicate samples as indicated. The
molecular weight standard (MW) is given. (B) cRNA samples which were
in some cases pooled together are summarized. (C) False-color images of
the GeneChips hybridized with replicate targets (R1, R2) prepared from
normal and mutant samples at the time-points indicated are shown to
control for hybridization artifacts. (D) A plot of probe intensities (y-axis)
against oligonucleotide probes (x-axis) is shown. (E) A box plot displays
log2 intensities (y-axis) for all samples (x-axis) before normalization.
Additional file 2: Supplemental Table S1: Gene annotation and
expression profiling output. This file is in the MS xls format and
contains information about genes including identifiers, probe set IDs, GO
terms and color-coded, normalized, and log2 transformed expression
data. Users are able to call up data for individual genes or lists of loci
using the search and filtering options of MS Excel.
Acknowledgements
We thank B. Jégou for critical reading of the manuscript, H. Scherthan and J.
Moore for stimulating discussions and O. Collin (IRISA, GenOuest bioinformatics
platform) for MIMAS and GermOnline system administration. A. Lardenois was
supported by an Inserm Young Investigator fellowship and INERIS. This work was
supported by Deutsche Forschungsgemeinschaft grant Sche 195/15 awarded to
G. Scherer and by Inserm Avenir grant R07216NS awarded to M. Primig.
Lardenois et al. Reproductive Biology and Endocrinology 2010, 8:154
http://www.rbej.com/content/8/1/154
Page 10 of 12
Author details
1Inserm, U625, Université de Rennes 1, IFR140, Rennes, F-35042, France.
2Institute of Human Genetics, University of Freiburg, Freiburg, D-79106,
Germany. 3Biozentrum, University of Basel, Basel, CH-4056, Switzerland.
4Departamento de Genética e Instituto de Biotecnología, University of
Granada, Granada, Spain.
Authors’ contributions
AL and FC analysed and interpreted expression, promoter motif prediction
and regulatory network data, FB prepared the testicular samples, PD
produced and quality controlled raw microarray data, GS designed research,
MP interpreted data and wrote the manuscript. All authors read and
approved the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 11 November 2010 Accepted: 23 December 2010
Published: 23 December 2010
References
1. Sekido R, Lovell-Badge R: Sex determination involves synergistic action of
SRY and SF1 on a specific Sox9 enhancer. Nature 2008,
453(7197):930-934.
2. Sekido R, Lovell-Badge R: Sex determination and SRY: down to a wink
and a nudge? Trends Genet 2009, 25(1):19-29.
3. Gordon CT, Tan TY, Benko S, Fitzpatrick D, Lyonnet S, Farlie PG: Long-range
regulation at the SOX9 locus in development and disease. J Med Genet
2009, 46(10):649-656.
4. Sekido R, Bar I, Narvaez V, Penny G, Lovell-Badge R: SOX9 is up-regulated
by the transient expression of SRY specifically in Sertoli cell precursors.
Dev Biol 2004, 274(2):271-279.
5. Kent J, Wheatley SC, Andrews JE, Sinclair AH, Koopman P: A male-specific
role for SOX9 in vertebrate sex determination. Development 1996,
122(9):2813-2822.
6. Morais da Silva S, Hacker A, Harley V, Goodfellow P, Swain A, Lovell-
Badge R: Sox9 expression during gonadal development implies a
conserved role for the gene in testis differentiation in mammals and
birds. Nat Genet 1996, 14(1):62-68.
7. Petersen C, Soder O: The sertoli cell–a hormonal target and ‘super’ nurse
for germ cells that determines testicular size. Horm Res 2006,
66(4):153-161.
8. Griswold MD: The central role of Sertoli cells in spermatogenesis. Semin
Cell Dev Biol 1998, 9(4):411-416.
9. Gasca S, Canizares J, De Santa Barbara P, Mejean C, Poulat F, Berta P, Boizet-
Bonhoure B: A nuclear export signal within the high mobility group
domain regulates the nucleocytoplasmic translocation of SOX9 during
sexual determination. Proc Natl Acad Sci USA 2002, 99(17):11199-11204.
10. Malki S, Nef S, Notarnicola C, Thevenet L, Gasca S, Mejean C, Berta P,
Poulat F, Boizet-Bonhoure B: Prostaglandin D2 induces nuclear import of
the sex-determining factor SOX9 via its cAMP-PKA phosphorylation.
EMBO J 2005, 24(10):1798-1809.
11. Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE: Structural basis for
DNA bending by the architectural transcription factor LEF-1. Nature 1995,
376(6543):791-795.
12. Harley VR, Clarkson MJ, Argentaro A: The molecular action and regulation
of the testis-determining factors, SRY (sex-determining region on the Y
chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9].
Endocr Rev 2003, 24(4):466-487.
13. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA,
Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN, et al:
Campomelic dysplasia and autosomal sex reversal caused by mutations
in an SRY-related gene. Nature 1994, 372(6506):525-530.
14. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J,
Bricarelli FD, Keutel J, Hustert E, et al: Autosomal sex reversal and
campomelic dysplasia are caused by mutations in and around the SRY-
related gene SOX9. Cell 1994, 79(6):1111-1120.
15. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B: Sox9 is
required for cartilage formation. Nat Genet 1999, 22(1):85-89.
16. Barrionuevo F, Bagheri-Fam S, Klattig J, Kist R, Taketo MM, Englert C,
Scherer G: Homozygous inactivation of Sox9 causes complete XY sex
reversal in mice. Biol Reprod 2006, 74(1):195-201.
17. Chaboissier MC, Kobayashi A, Vidal VI, Lutzkendorf S, van de Kant HJ,
Wegner M, de Rooij DG, Behringer RR, Schedl A: Functional analysis of
Sox8 and Sox9 during sex determination in the mouse. Development
2004, 131(9):1891-1901.
18. Barrionuevo F, Georg I, Scherthan H, Lecureuil C, Guillou F, Wegner M,
Scherer G: Testis cord differentiation after the sex determination stage is
independent of Sox9 but fails in the combined absence of Sox9 and
Sox8. Dev Biol 2009, 327(2):301-312.
19. Barrionuevo F, Scherer G: SOX E genes: SOX9 and SOX8 in mammalian
testis development. Int J Biochem Cell Biol 2009, 42(3):433-436.
20. Kist R, Schrewe H, Balling R, Scherer G: Conditional inactivation of Sox9: a
mouse model for campomelic dysplasia. Genesis 2002, 32(2):121-123.
21. Lecureuil C, Fontaine I, Crepieux P, Guillou F: Sertoli and granulosa cell-
specific Cre recombinase activity in transgenic mice. Genesis 2002,
33(3):114-118.
22. Chalmel F, Rolland AD, Niederhauser-Wiederkehr C, Chung SS, Demougin P,
Gattiker A, Moore J, Patard JJ, Wolgemuth DJ, Jegou B, et al: The
conserved transcriptome in human and rodent male gametogenesis.
Proc Natl Acad Sci USA 2007, 104(20):8346-8351.
23. Chalmel F, Primig M: The Annotation, Mapping, Expression and Network
(AMEN) suite of tools for molecular systems biology. BMC Bioinformatics
2008, 9:86.
24. Schlecht U, Demougin P, Koch R, Hermida L, Wiederkehr C, Descombes P,
Pineau C, Jegou B, Primig M: Expression profiling of mammalian male
meiosis and gametogenesis identifies novel candidate genes for roles in
the regulation of fertility. Mol Biol Cell 2004, 15(3):1031-1043.
25. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I,
Chekmenev D, Krull M, Hornischer K, et al: TRANSFAC and its module
TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic
Acids Res 2006, , 34 Database: D108-110.
26. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, Fujita PA,
Diekhans M, Smith KE, Rosenbloom KR, Raney BJ, et al: The UCSC Genome
Browser database: update 2010. Nucleic Acids Res 2010, , 38 Database:
D613-619.
27. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV,
Wingender E: MATCH: A tool for searching transcription factor binding
sites in DNA sequences. Nucleic Acids Res 2003, 31(13):3576-3579.
28. Wasserman WW, Palumbo M, Thompson W, Fickett JW, Lawrence CE:
Human-mouse genome comparisons to locate regulatory sites. Nat
Genet 2000, 26(2):225-228.
29. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K,
Clawson H, Spieth J, Hillier LW, Richards S, et al: Evolutionarily conserved
elements in vertebrate, insect, worm, and yeast genomes. Genome Res
2005, 15(8):1034-1050.
30. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M,
Abeygunawardena N, Berube H, Dylag M, Emam I, Farne A, et al:
ArrayExpress update–from an archive of functional genomics
experiments to the atlas of gene expression. Nucleic Acids Res 2009, , 37
Database: D868-872.
31. Gattiker A, Niederhauser-Wiederkehr C, Moore J, Hermida L, Primig M: The
GermOnline cross-species systems browser provides comprehensive
information on genes and gene products relevant for sexual
reproduction. Nucleic Acids Res 2007, , 35 Database: D457-462.
32. Chu TM, Deng S, Wolfinger R, Paules RS, Hamadeh HK: Cross-site
comparison of gene expression data reveals high similarity. Environ
Health Perspect 2004, 112(4):449-455.
33. Auer H, Newsom DL, Kornacker K: Expression Profiling Using Affymetrix
GeneChip Microarrays. Methods Mol Biol 2009, 509:35-46.
34. Wrobel G, Primig M: Mammalian male germ cells are fertile ground for
expression profiling of sexual reproduction. Reproduction 2005, 129(1):1-7.
35. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M,
Marshall KA, Phillippy KH, Sherman PM, et al: NCBI GEO: archive for functional
genomics data sets–10 years on. Nucleic Acids Res 2010.
36. Lardenois A, Gattiker A, Collin O, Chalmel F, Primig M: GermOnline 4.0 is a
genomics gateway for germline development, meiosis and the mitotic
cell cycle. Database (Oxford) 2010, baq030.
Lardenois et al. Reproductive Biology and Endocrinology 2010, 8:154
http://www.rbej.com/content/8/1/154
Page 11 of 12
37. Maclean JA, Wilkinson MF: Gene regulation in spermatogenesis. Curr Top
Dev Biol 2005, 71:131-197.
38. Abu-Elheiga L, Matzuk MM, Kordari P, Oh W, Shaikenov T, Gu Z, Wakil SJ:
Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.
Proc Natl Acad Sci USA 2005, 102(34):12011-12016.
39. Campagnoni AT, Skoff RP: The pathobiology of myelin mutants reveal
novel biological functions of the MBP and PLP genes. Brain Pathol 2001,
11(1):74-91.
40. Scotland P, Zhou D, Benveniste H, Bennett V: Nervous system defects of
AnkyrinB (-/-) mice suggest functional overlap between the cell
adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons.
J Cell Biol 1998, 143(5):1305-1315.
41. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH,
Song LS, Haurogne K, Kyndt F, Ali ME, et al: Ankyrin-B mutation causes
type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature
2003, 421(6923):634-639.
42. Connor F, Wright E, Denny P, Koopman P, Ashworth A: The Sry-related
HMG box-containing gene Sox6 is expressed in the adult testis and
developing nervous system of the mouse. Nucleic Acids Res 1995,
23(17):3365-3372.
43. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B: The
transcription factor Sox9 has essential roles in successive steps of the
chondrocyte differentiation pathway and is required for expression of
Sox5 and Sox6. Genes Dev 2002, 16(21):2813-2828.
44. Ikeda T, Saito T, Ushita M, Yano F, Kan A, Itaka K, Moro T, Nakamura K,
Kawaguchi H, Chung UI: Identification and characterization of the human
SOX6 promoter. Biochem Biophys Res Commun 2007, 357(2):383-390.
45. Han Y, Lefebvre V: L-Sox5 and Sox6 drive expression of the aggrecan
gene in cartilage by securing binding of Sox9 to a far-upstream
enhancer. Mol Cell Biol 2008, 28(16):4999-5013.
46. Weise A, Bruser K, Elfert S, Wallmen B, Wittel Y, Wohrle S, Hecht A:
Alternative splicing of Tcf7l2 transcripts generates protein variants with
differential promoter-binding and transcriptional activation properties at
Wnt/beta-catenin targets. Nucleic Acids Res 2010, 38(6):1964-1981.
47. Faro A, Boj SF, Ambrosio R, van den Broek O, Korving J, Clevers H: T-cell
factor 4 (tcf7l2) is the main effector of Wnt signaling during zebrafish
intestine organogenesis. Zebrafish 2009, 6(1):59-68.
48. Topol L, Chen W, Song H, Day TF, Yang Y: Sox9 inhibits Wnt signaling by
promoting beta-catenin phosphorylation in the nucleus. J Biol Chem
2009, 284(5):3323-3333.
49. Boyer A, Hermo L, Paquet M, Robaire B, Boerboom D: Seminiferous tubule
degeneration and infertility in mice with sustained activation of WNT/
CTNNB1 signaling in sertoli cells. Biol Reprod 2008, 79(3):475-485.
50. Tanwar PS, Kaneko-Tarui T, Zhang L, Rani P, Taketo MM, Teixeira J:
Constitutive WNT/beta-catenin signaling in murine Sertoli cells disrupts
their differentiation and ability to support spermatogenesis. Biol Reprod
2009, 82(2):422-432.
51. Laurich VM, Trbovich AM, O’Neill FH, Houk CP, Sluss PM, Payne AH,
Donahoe PK, Teixeira J: Mullerian inhibiting substance blocks the protein
kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C
(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP
responsive element binding protein phosphorylation. Endocrinology 2002,
143(9):3351-3360.
52. Hu L, Monteiro A, Johnston H, King P, O’Shaughnessy PJ: Expression of
Cyp21a1 and Cyp11b1 in the fetal mouse testis. Reproduction 2007,
134(4):585-591.
53. Kostic TS, Stojkov NJ, Janjic MM, Andric SA: Structural complexity of the
testis and PKG I/StAR interaction regulate the Leydig cell adaptive
response to repeated immobilization stress. Int J Androl 2009,
33(5):717-729.
54. Qin J, Tsai MJ, Tsai SY: Essential roles of COUP-TFII in Leydig cell
differentiation and male fertility. PLoS One 2008, 3(9):e3285.
55. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP: Female development
in mammals is regulated by Wnt-4 signalling. Nature 1999,
397(6718):405-409.
56. Ottolenghi C, Pelosi E, Tran J, Colombino M, Douglass E, Nedorezov T,
Cao A, Forabosco A, Schlessinger D: Loss of Wnt4 and Foxl2 leads to
female-to-male sex reversal extending to germ cells. Hum Mol Genet
2007, 16(23):2795-2804.
57. Boyer A, Lapointe E, Zheng X, Cowan RG, Li H, Quirk SM, DeMayo FJ,
Richards JS, Boerboom D: WNT4 is required for normal ovarian follicle
development and female fertility. FASEB J 2010, 24(8):3010-3025.
58. Bernard P, Harley VR: Wnt4 action in gonadal development and sex
determination. Int J Biochem Cell Biol 2007, 39(1):31-43.
59. Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, Kress J, Treier AC,
Klugmann C, Klasen C, Holter NI, et al: Somatic sex reprogramming of
adult ovaries to testes by FOXL2 ablation. Cell 2009, 139(6):1130-1142.
60. Veitia RA: FOXL2 versus SOX9: a lifelong “battle of the sexes”. Bioessays
2010, 32(5):375-380.
61. Charron Y, Madani R, Nef S, Combepine C, Govin J, Khochbin S, Vassalli JD:
Expression of serpinb6 serpins in germ and somatic cells of mouse
gonads. Mol Reprod Dev 2006, 73(1):9-19.
62. Heutinck KM, ten Berge IJ, Hack CE, Hamann J, Rowshani AT: Serine
proteases of the human immune system in health and disease. Mol
Immunol 2010, 47(11-12):1943-1955.
63. Kaiserman D, Bird PI: Control of granzymes by serpins. Cell Death Differ
2009, 17(4):586-595.
64. Sipione S, Simmen KC, Lord SJ, Motyka B, Ewen C, Shostak I, Rayat GR,
Dufour JM, Korbutt GS, Rajotte RV, et al: Identification of a novel human
granzyme B inhibitor secreted by cultured sertoli cells. J Immunol 2006,
177(8):5051-5058.
65. Odet F, Verot A, Le Magueresse-Battistoni B: The mouse testis is the
source of various serine proteases and serine proteinase inhibitors
(SERPINs): Serine proteases and SERPINs identified in Leydig cells are
under gonadotropin regulation. Endocrinology 2006, 147(9):4374-4383.
66. Uhrin P, Dewerchin M, Hilpert M, Chrenek P, Schofer C, Zechmeister-
Machhart M, Kronke G, Vales A, Carmeliet P, Binder BR, et al: Disruption of
the protein C inhibitor gene results in impaired spermatogenesis and
male infertility. J Clin Invest 2000, 106(12):1531-1539.
67. Denhardt DT, Giachelli CM, Rittling SR: Role of osteopontin in cellular
signaling and toxicant injury. Annu Rev Pharmacol Toxicol 2001,
41:723-749.
68. Spiess AN, Feig C, Schulze W, Chalmel F, Cappallo-Obermann H, Primig M,
Kirchhoff C: Cross-platform gene expression signature of human
spermatogenic failure reveals inflammatory-like response. Hum Reprod
2007, 22(11):2936-2946.
69. Bondeson J, Wainwright S, Hughes C, Caterson B: The regulation of the
ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin
Exp Rheumatol 2008, 26(1):139-145.
70. Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY,
Xu B, Lu MM, Zhou D, et al: Platelets regulate lymphatic vascular
development through CLEC-2-SLP-76 signaling. Blood 2010,
116(4):661-670.
71. Pham CT, Ley TJ: Dipeptidyl peptidase I is required for the processing
and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA
1999, 96(15):8627-8632.
72. Ohashi R, Mu H, Yao Q, Chen C: Cellular and molecular mechanisms of
atherosclerosis with mouse models. Trends Cardiovasc Med 2004,
14(5):187-190.
73. Pappas DJ, Coppola G, Gabatto PA, Gao F, Geschwind DH, Oksenberg JR,
Baranzini SE: Longitudinal system-based analysis of transcriptional
responses to type I interferons. Physiol Genomics 2009, 38(3):362-371.
74. Wohlfahrt-Veje C, Main KM, Skakkebaek NE: Testicular dysgenesis
syndrome: foetal origin of adult reproductive problems. Clin Endocrinol
(Oxf) 2009, 71(4):459-465.
doi:10.1186/1477-7827-8-154
Cite this article as: Lardenois et al.: Profiling spermatogenic failure in
adult testes bearing Sox9-deficient Sertoli cells identifies genes involved
in feminization, inflammation and stress. Reproductive Biology and
Endocrinology 2010 8:154.
Lardenois et al. Reproductive Biology and Endocrinology 2010, 8:154
http://www.rbej.com/content/8/1/154
Page 12 of 12
